ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹û

XClose

ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûNews

Home
Menu

Alzheimer’s: A Turning Point?

13 February 2024

Two new drugs that can be used to slow the progression of Alzheimer's disease, donanemab and lecanemab, represent a turning point in Alzheimer's research, believes Dr Cath Mummery (ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûQueen Square Institute of Neurology), but she adds they are "just the beginning".

,